Monday, Nov 17th
Last update10:22:33 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
 This fall, multiple states including Maryland, Virginia, Tennessee and Wisconsin have reported outbreaks of hand, foot... |
 A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly... | ||
|
 Cancer continues to be one of the world's top causes of death, due in part to... |
